Pharm 101: CeftriaxoneACEM Primary Pharmacology of Ceftriaxone: the Pharmacokinetics; Pharmacodynamics; Clinical uses; Adverse effectsRobert ButtnerFebruary 8, 2020
Pharm 101: AzithromycinACEM Primary Pharmacology of Azithromycin: the Pharmacokinetics; Pharmacodynamics; Clinical uses; Adverse effectsRobert ButtnerFebruary 8, 2020
Pharm 101: LevodopaACEM Primary Pharmacology of Levodopa: the Pharmacokinetics; Pharmacodynamics; Clinical uses; Adverse effectsRobert ButtnerFebruary 8, 2020
Pharm 101: FluoxetineACEM Primary Pharmacology of Fluoxetine: the Pharmacokinetics; Pharmacodynamics; Clinical uses; Adverse effectsRobert ButtnerFebruary 8, 2020
Pharm 101: SumatriptanACEM Primary Pharmacology of Sumatriptan: the Pharmacokinetics; Pharmacodynamics; Clinical uses; Adverse effectsRobert ButtnerFebruary 8, 2020
Pharm 101: SuxamethoniumACEM Primary Pharmacology of Suxamethnoium: the Pharmacokinetics; Pharmacodynamics; Clinical uses; Adverse effectsRobert ButtnerFebruary 5, 2020
Pharm 101: RocuroniumACEM Primary Pharmacology of Rocuronium: the Pharmacokinetics; Pharmacodynamics; Clinical uses; ReversalRobert ButtnerFebruary 1, 2020
Pharm 101: SalbutamolACEM Primary Pharmacology of Salbutamol: the Pharmacokinetics; Pharmacodynamics; Clinical uses; Adverse effectsRobert ButtnerFebruary 1, 2020
Pharm 101: Glycerol trinitrate (GTN)ACEM Primary Pharmacology of GTN: the Pharmacokinetics; Pharmacodynamics; Clinical uses; Adverse effectsRobert ButtnerJanuary 2, 2020
Alteplase (rtPA)Alteplase is a tissue plasminogen activator used as a thrombolytic medication in: Acute Ischaemic Strokes, Acute Myocardial Infarction and PEJames Pearlman and Chris NicksonJanuary 5, 2019
Tenecteplase (TNK-tPA)Tenecteplase is a tissue plasminogen activator used as a thrombolytic medication in: Acute Ischaemic Strokes, Acute Myocardial Infarction, PEJames Pearlman and Chris NicksonJanuary 4, 2019
R&R In The FASTLANE 124Welcome to the 124th edition of Research and Reviews in the Fastlane. R&R in the Fastlane reviews the best and worst of global critical care researchSøren RudolphMarch 3, 2016